AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Tagliaferri, M Berselli, ME Calo, G Minocci, A Savia, G Petroni, ML Viberti, GC Liuzzi, A
Citation: M. Tagliaferri et al., Subclinical hypothyroidism in obese patients: Relation to resting energy expenditure, serum leptin, body composition, and lipid profile, OBES RES, 9(3), 2001, pp. 196-201

Authors: Collins, ACG Vincent, J Newall, RG Mitchell, KM Viberti, GC
Citation: Acg. Collins et al., An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic, DIABET MED, 18(11), 2001, pp. 928-932

Authors: Earle, KA Mishra, B Morocutti, A Barnes, D Chambers, J Viberti, GC
Citation: Ka. Earle et al., QT dispersion in microalbuminuric Type 1 diabetic patients without myocardial ischemia, J DIABET C, 14(5), 2000, pp. 277-280

Authors: Thomas, SM Viberti, GC
Citation: Sm. Thomas et Gc. Viberti, Is it possible to predict diabetic kidney disease?, J ENDOC INV, 23(1), 2000, pp. 44-53

Authors: Minocci, A Savia, G Lucantoni, R Berselli, ME Tagliaferri, M Calo, G Petroni, ML de Medici, C Viberti, GC Liuzzi, A
Citation: A. Minocci et al., Leptin plasma concentrations are dependent on body fat distribution in obese patients, INT J OBES, 24(9), 2000, pp. 1139-1144

Authors: Viberti, GC Thomas, SM
Citation: Gc. Viberti et Sm. Thomas, Searching for new coronary heart disease risk factors, EUR HEART J, 21(23), 2000, pp. 1905-1906

Authors: Marre, M Lievre, M Vasmant, D Gallois, Y Hadjadj, S Reglier, JC Chatellier, G Mann, J Viberti, GC Passa, P
Citation: M. Marre et al., Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa, DIABET CARE, 23, 2000, pp. B40-B48

Authors: O'Hare, JP Bilous, R Mitchell, T O'Callaghan, CJ Viberti, GC Willoughby, R Riley, J Robinson, AM Reckless, JP Havard, F Sampson, M Lloyd, A Williams, T Vora, J Chattington, P Hampson, K Ibrahim, H Borthwick, L Willoughby, R Viberti, G Russell, C Barnes, D Macklin, A Murphy, E Stephens, E Vincent, J Tindall, H Simpson, H Knowles, E Cunningham, B Simpson, E Bilous, R Bilous, M Mitchell, T O'Halloran, D Nugent, S Hadden, D Fetherstone, M McCarton, D McGurk, C Johnston, C Burton, J Harris, C Hempstead, H Baksi, A Bartlett, J Heaton, C Brown, K Arora, A Burke, J Najim, V Cassar, J Coppini, D Chazan, B Kennedy, R Smith, J Flynn, M Lewis, A Jeffcoate, W Peck, G Pound, N Large, D Clarke, M Llewellyn, H Ang, H Davidson, G McKenna, T Byrne, P Fiad, T Hayes, F McGra, J Peters, J Davies, M Press, M Price, D Jones, L Wareham, K Scarpello, J Hodgson, E Scott, R Chaudry, A Lord, G Parsons, D Smyth, C Tymms, D Fairhurst, M White, M Hepburn, D Beer, J Nasir, J Smith, C Lenox-Smith, A Braithwaite, I Riley, J Michael, A Seymour, I Laffealy, S Johnson, W Patel, S Halls, H Davall, H Schyns, C
Citation: Jp. O'Hare et al., Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension results of a randomized controlled trial - Results of a randomized controlled trial, DIABET CARE, 23(12), 2000, pp. 1823-1829

Authors: Thomas, S Viberti, GC
Citation: S. Thomas et Gc. Viberti, Proteinuria in diabetes, J ROY COL P, 34(4), 2000, pp. 336-339

Authors: Bacci, S De Cosmo, S Garruba, M Placentino, G Liuzzi, A Barbano, F Di Giorgio, A Trischitta, V Viberti, GC
Citation: S. Bacci et al., Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients, DIABETOLOG, 43(7), 2000, pp. 922-926

Authors: De Cosmo, S Argiolas, A Miscio, G Thomas, S Piras, GP Trevisan, R Perin, PC Bacci, S Zucaro, L Margaglione, M Frittitta, L Pizzuti, A Tassi, V Viberti, GC Trischitta, V
Citation: S. De Cosmo et al., A PC-1 amino acid variant (K121Q) is associated with faster progression ofrenal disease in patients with type 1 diabetes and albuminuria, DIABETES, 49(3), 2000, pp. 521-524

Authors: Ceriello, A Morocutti, A Mercuri, F Quagliaro, L Moro, M Damante, G Viberti, GC
Citation: A. Ceriello et al., Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy, DIABETES, 49(12), 2000, pp. 2170-2177

Authors: Thomas, SM Gruden, G Viberti, GC
Citation: Sm. Thomas et al., The pathophysiology of hypertension in diabetes: Microvascular complications, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 257-266

Authors: De Cosmo, S Margaglione, M Tassi, V Garrubba, M Thomas, S Olivetti, C Piras, GP Trevisan, R Vedovato, M Perin, PC Bacci, S Colaizzo, D Cisternino, C Zucaro, L Di Minno, G Trischitta, V Viberti, GC
Citation: S. De Cosmo et al., ACE, PAI-1, decorin and Warner helicase genes are not associated with the development of renal disease in European patients with Type 1 diabetes, DIABET M R, 15(4), 1999, pp. 247-253

Authors: Liuzzi, A Savia, G Tagliaferri, M Lucantoni, R Berselli, ME Petroni, ML De Medici, C Viberti, GC
Citation: A. Liuzzi et al., Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors, INT J OBES, 23(10), 1999, pp. 1066-1073
Risultati: 1-15 |